Chronic kidney disease (CKD) is a complex and multifactorial disease, and one of the most
prevalent worldwide. Chronic kidney disease–mineral bone disorders (CKD–MBD) with …

This paper reviews the scientific knowledge on the use of a lanthanum modified bentonite
(LMB) to manage eutrophication in surface water. The LMB has been applied in around 200 …

The importance of phosphate homeostasis in chronic kidney disease (CKD) has been
recognized for decades, but novel insights—which are frequently relevant to everyday …

Background Phosphate binders are used to reduce positive phosphate balance and to lower
serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …

It is commonly held that osteitis fibrosa and mixed uremic osteodystrophy are the
predominant forms of renal osteodystrophy in patients with chronic kidney disease. Osteitis …

Hyperphosphatemia, which is nearly universal in kidney failure, is accompanied by low
serum levels of vitamin D and hypocalcemia. Without treatment, severe secondary …

Abstract Background and aims Rare Earth Elements (REE) are widely used to trace natural
geochemical processes. They are also increasingly used by man (electronics industry …

Renal osteodystrophy occurs early during loss of kidney function. There are 26 million
American patients with chronic kidney disease (CKD), and almost all patients with CKD …

Arterial disease in CKD patients is characterized by extensive calcification. Evidence has
accumulated pointing to the active and regulated nature of the calcification process …

Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering
condition that can lead to cardiovascular calcification, metabolic bone disease (renal …